Chemoprevention in bladder cancer: What's new?

Journal of the Canadian Urological Association

Volumn 3, Issue 6 SUPPL. 4, 2009, Pages

  Lattouf, Jean Baptiste ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 75849125843     PISSN: 19116470     EISSN: 19116470     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. Ohno Y, Aoki K, Obata K, et al. Case Control Study of Urinary Bladder Cancer in Metropolitan Nagoya. Natl Cancer Inst Monogr 1985;69:229-34.
2. Lynch CF, Cohen MB. Urinary System. Cancer 1995;75:316-29.
3. Braver DJ, Modan M, Chêtrit A, et al. Drinking, Micturition Habits, and Urine Concentration as Potential Risk Factors in Urinary Bladder Cancer. J Natl Cancer Inst 1987;78:437-40.
4. Michaud DS, Spiegelman D, Clinton SK, et al. Fluid Intake and the Risk of Bladder Cancer in Men. N Engl J Med 1999;340:1390-7.
5. Geoffroy-Perez B, Cordier S. Fluid consumption and the risk of bladder cancer: Results of a multicenter case-control study. Int J Cancer 2001;93:880-7.
6. Sala M, Cordier S, Chang-Claude J, et al. Coffee consumption and bladder cancer in nonsmokers: a pooled analysis of case-control studies in European countries. Cancer Causes and Control 2000;11:925-31.
7. Riboli E, Gonzalez CA, Lopez-Abente G, et al. Diet and Bladder Cancer in Spain: A Multi-Center Case-Control Study. Int J Cancer 1991;49:214-9.
8. Bruemmer B, White E, Vaughan TL, et al. Nutrient Intake in Relation to Bladder Cancer among Middle-aged Men and Women. Am J Epidemiol 1996;144:485-95.
9. Steineck G, Hagman U, Gerhardsson M, et al. Vitamin A Supplements, Fried Foods, Fat and urothelial Cancer. A Case-Referent Study in Stockholm in 1985-87. Int J Cancer 1990;45:1006-11.
10. Steinmaus CM, Nuñez S, Smith AH. Diet and Bladder Cancer: A Meta-analysis of Six Dietary Variables. Am J Epidemiol 2000;151:693-702.
11. Michaud DS, Spiegelman D, Clinton SK, et al. Prospective Study of Dietary Supplements, Macronutrients, Micronutrients, and Risk of Bladder Cancer in US Men. Am J Epidemiol 2000;152:1145-53.
12. Xu GP, Song PJ, Reed PI. Effects of Fruit Juices, Processed Vegetable Juice, Orange Peel and Green Tea on Endogenous Formation of N-Nitrosoproline in Subjects from a High-Risk Area for Gastric Cancer in Moping County, China. Eur J Cancer Prev 1993;2:327-35.
13. Steele VE, Kelloff GJ, Balentine D, et al. Comparative chemopreventive mechanisms of green tea, black tea and selected polyphenol extracts measured by in vitro bioassays. Carcinogenesis 2000;21:63-7.
14. Kemberling JK, Hampton JA, Keck RW, et al. Inhibition of Bladder Tumor Growth by the Green Tea Derivative Epigallocatechin-3-Gallate. J Urol 2003;170:773-6.
15. Roomi MW, Ivanov V, Kalinovsky T, et al. Antitumor Effect of Ascorbic Acid, Lysine, Proline, Arginine, and Green Tea Extract on Bladder Cancer Cell Line T-24. Int J Urol 2006;13:415-9.
16. Nakata S, Sato J, Yamanaka H. Correlation Analysis Between Bladder Cancer and Cigarette Smoking in Various Countries. Tohoku J Ext Med 1996;178:169-76.
17. Bianchi GD, Cerhan JR, Parker AS, et al. Tea Consumption and Risk of Bladder and Kidney Cancers In a Population-based Case-Control Study. Am J Epidemiol 2000;151:377-83.
18. Clinical Trials. National Cancer Institute website. http://www.cancer.gov/CLINICALTRIALS. Accessed November 18, 2009
19. Su S-J, Yeh T-M, Lei H-Y, et al. The Potential of Soybean Foods as a Chemoprevention Approach for Human Urinary Tract Cancer. Clin Cancer Res 2000;6:230-6.
20. Sun C-L, Yuan J-M, Arakawa K, et al. Dietary Soy and Increased Risk of Bladder Cancer: the Singapore Chinese Health Study. Cancer Epidemiol Biomarkers Prev 2002;11:1674-7.
21. Castelao JE, Yuan JM, Gago-Dominguez M, et al. Carotenoids/Vitamin C and Smoking Related Bladder Cancer. Int J Cancer 2004;110:417-23.
22. Decensi A, Torrisi R, Bruno S, et al. Randomized Trial of Fenretinide in Superficial Bladder Cancer Using DNA Flow Cytometry as an Intermediate End Point. Cancer Epidemiol Biomarkers Prev 2000;9:1071-8.
23. Studer UE, Jenzer S, Biedermann C, et al. Adjuvant Treatment with Vitamin A Analogue (Etretinate) After Transurethral Resection of Superficial Bladder Tumors. Final Analysis of a Prospective, Randomized Multicenter Trial in Switzerland. Eur Urol 1995;28:284-90.
24. Prout JRJ, Barton BA. 13-cis-Retinoic Acid in Chemoprevention of Superficial Bladder Cancer. The National Bladder Cancer Group. J Cell Biochem Suppl 1992;16I:148-52.
25. Byar D, Blackard C. Comparisons of Placebo, Pyridoxine, and Topical Thiotepa in Preventing Recurrence of Stage I Bladder Cancer. Urology 1977;10:556-61.
26. Newling DW, Robinson MR, Smith PH, et al. Tryptophan Metabolites, Pyridoxine (Vitamin B6) and their Influence on the Recurrence Rate of Superficial Bladder Cancer. Results of a Prospective, Randomized Phase III Study Performed by the EORTC GU Group. EORTC Genito-Urinary Tract Cancer Cooperative Group. Eur Urol 1995;27:110-6.
27. Shibata A, Paganini-Hill A, Ross RK, et al. Intake of Vegetables, Fruits, Beta-Carotenes, Vitamin C and Vitamin Supplements and Cancer Incidence Among the Elderly: A Prospective Study. Br J Cancer 1992;66:673-9.
28. Nomura AM, Kolonel LN, Hankin JH, et al. Dietary Factors in Cancer of the Lower Urinary Tract. Int J Cancer 1991;48:199-205.
29. Jacobs EJ, Henion AK, Briggs PJ, et al. Vitamin C and Vitamin E Supplement Use and Bladder Cancer Mortality in a Large Cohort of US Men and Women. Am J Epidemiol 2002;156:1002-10.
30. Miller ER III, Pastor-Barriuso R, Dalal D, et al. Meta-Analysis: High-Dosage Vitamin E Supplementation May Increase All-Cause Mortality. Ann Intern Med 2005;142:37-46.
31. Lamm DL, Riggs DR, Shriver JS, et al. Megadose Vitamins in Bladder Cancer: A Double-Blind Clinical Trial. J Urol. 1994;151:21-6.
32. Helzlsouer KJ, Comstock GW, Morris JS. Selenium, Lycopene, {alpha}-Tocopherol, {beta}-Carotene, Retinol, and Subsequent Bladder Cancer. Cancer Res 1989;49:6144-8.
33. Garland M, Morris JS, Stampfer MJ, et al. Prospective Study of Toenail Selenium Levels and Cancer Among Women. J Natl Cancer Inst 1995;87:497-505.
34. Komhoff M, Guan Y, Shappell HW, et al. Enhanced Expression of Cyclooxygenase-2 in High Grade Human Transitional Cell Bladder Carcinomas. Am J Pathol 2000;157:29-35.
35. Shirahama T. Cyclooxygenase-2 Expression Is Up-Regulated in Transitional Cell Carcinoma and Its Preneoplastic Lesions in the Human Urinary Bladder. Clin Cancer Res 2000;6:2424-30.
36. Castelao JE, Yuan JM, Gago-Dominguez M, et al. Non-steroidal anti-inflammatory drugs and bladder cancer prevention. Br J Cancer 2000;82:1364-9.
37. Lerner SP. Bladder cancer clinical trials. Urol Oncol 2005;23:275-9.
38. Messing EM, Kim KM, Sharkey F, et al. Randomized Prospective Phase III trial of Difluoromethylornithine vs Placebo in Preventing Recurrence of Completely Resected Low Risk Superficial Bladder Cancer. J Urol 2006;176:500-4.